Meta-Analysishigh evidence
Intradiscal mesenchymal stem cell therapy for degenerative disc disease: a systematic review and meta-analysis of randomized trials.
Asian spine journal·June 1, 2026·PMID 41844059
Why it mattersFor pain specialists managing refractory discogenic low-back pain, this meta-analysis provides pooled evidence that intradiscal MSC therapy offers a safe, modestly effective option beyond conservative care, helping to inform discussions on emerging regenerative interventions.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled